Bristol Myers Squibb (BMS) has shared positive top-line results from two late-stage studies of its oral TYK2 inhibitor ...

Axsome Therapeutics has announced that it has successfully completed its late-stage clinical programme evaluating ...

Events 4 Healthcare specialise in delivering bespoke events for the Healthcare and Pharmaceutical industry. We conceive and deliver Joint Working projects and produce medical education programmes, ...

Gower is recognised as one of the world’s leading publishers of specialist business and management books and resources. Our publishing programme covers many of the main business processes and ...

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us a unique perspective in healthcare marketing. We’re ideally ...

Step into the future of medical education with our exclusive webinar series from February 25-26, designed specifically for Pharma leaders. This transformative series will showcase the 2025 Pharma ...

Is your medical education strategy reaching the right HCPs in the formats they prefer? Discover actionable insights to elevate the impact of your medical education efforts in the latest Medical ...

AstraZeneca’s Tagrisso (osimertinib) has been approved by the European Commission (EC) to treat a new subset of lung cancer patients. The epidermal growth factor receptor (EGFR)-tyrosine kinase ...

Pfizer’s Braftovi (encorafenib) regimen has been granted accelerated approval by the US Food and Drug Administration (FDA) to treat metastatic colorectal cancer (mCRC). The drug has been authorised ...

For many years the pharma sector has been vocal in its commitment to a ‘patient-focused’ approach. As a result, there does seem to be more attention on the patient across med affairs, marketing and ...

As the world’s third largest pharmaceutical market, Japan accounted for approximately 6% of the $1.5tn in global pharmaceutical sales in 2022. While this makes it an attractive market for all ...

Polymorphic Marketing Limited is a boutique marketing agency specialising in life science, biotechnology, laboratory consumables and scientific equipment marketing.